JUN 10, 2016 8:00 AM PDT

Lupus Anticoagulant (LA): Choosing the Right Testing Strategy for Your Laboratory

Sponsored by: Diagnostica Stago, Inc.
  • Oksana Volod, MD

    Associate Professor of Pathology at the Cedars Sinai Medical Center (CSMC) and University of California Los Angeles Hospital


Lupus anticoagulants are markers of prothrombotic potential which may be indicative of underlying antiphospholipid syndrome (aPS) requiring treatment with ongoing anticoagulants.  The purpose of this educational program is to update healthcare professionals regarding advancements in Lupus Anticoagulant (LA) testing. Current LA diagnostic guidelines, clinical evidence regarding LA significance, assay selection, and anticoagulant drugs interfering with LA testing will be discussed, along with clinical cases of high interest.

  • Describe role of Lupus Anticoagulant (LA) in Antiphospholipid Syndrome (APS).
  • Define current ISTH and CLSI Guidelines, identify tests, and define patient selection for appropriate LA work up.
  • Recognize medications that may cause false positive LA results.
  • Evaluate the right testing strategy for LA testing.
  • Correlate LA and APS to specific clinical cases.



P.A.C.E. ® Credits are no longer available for this webinar.

You May Also Like
Loading Comments...